REFERENCES
1. Schadendorf D, Lebbé C, zur Hausen
A, Avril M-F, Hariharan S, Bharmal M, et al. Merkel cell carcinoma:
epidemiology, prognosis, therapy and unmet medical needs. European
Journal of Cancer. 2017;71:53-69.
2. Becker JC, Stang A, DeCaprio JA,
Cerroni L, Lebbé C, Veness M, et al. Merkel cell carcinoma. Nature
Reviews Disease Primers. 2017;3:17077.
3. Higaki-Mori H, Kuwamoto S, Iwasaki
T, Kato M, Murakami I, Nagata K, et al. Association of Merkel cell
polyomavirus infection with clinicopathological differences in Merkel
cell carcinoma. Human pathology. 2012;43(12):2282-91.
4. Church CD, Nghiem P. How does the
Merkel polyomavirus lead to a lethal cancer? Many answers, many
questions, and a new mouse model. The Journal of investigative
dermatology. 2015;135(5):1221-4.
5. Wong SQ, Waldeck K, Vergara IA,
Schröder J, Madore J, Wilmott JS, et al. UV-associated mutations
underlie the etiology of MCV-negative Merkel cell carcinomas. Cancer
research. 2015;75(24):5228-34.
6. Lunder EJ, Stern RS. Merkel-cell
carcinomas in patients treated with methoxsalen and ultraviolet A
radiation. New England Journal of Medicine. 1998;339(17):1247-8.
7. Amaral T, Leiter U, Garbe C. Merkel
cell carcinoma: epidemiology, pathogenesis, diagnosis and therapy.
Reviews in Endocrine and Metabolic Disorders. 2017;18(4):517-32.
8. Goessling W, McKee PH, Mayer RJ.
Merkel cell carcinoma. Journal of clinical oncology. 2002;20(2):588-98.
9. McAfee WJ, Morris CG, Mendenhall
CM, Werning JW, Mendenhall NP, Mendenhall WM. Merkel cell carcinoma:
treatment and outcomes. Cancer. 2005;104(8):1761-4.
10. Agelli M, Clegg LX. Epidemiology
of primary Merkel cell carcinoma in the United States. Journal of the
American Academy of Dermatology. 2003;49(5):832-41.
11. Llombart B, Requena C, Cruz J.
Update on Merkel cell carcinoma: epidemiology, etiopathogenesis,
clinical features, diagnosis, and staging. Actas Dermo-Sifiliográficas
(English Edition). 2017;108(2):108-19.
12. Linjawi A, Jamison WB,
Meterissian S. Merkel cell carcinoma: important aspects of diagnosis and
management. The American surgeon. 2001;67(10):943.
13. Oh SI, Jin US, Chang H, Kwon ST,
Minn KW. A retrospective analysis of eight cases of Merkel cell
carcinoma. Archives of Craniofacial Surgery. 2013;14(1):41-5.
14. An KP, Ratner D. Merkel cell
carcinoma in the setting of HIV infection. Journal of the American
Academy of Dermatology. 2001;45(2):309-12.
15. Medina-Franco H, Urist MM,
Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of
Merkel cell carcinoma: case series and literature review of 1024 cases.
Annals of surgical oncology. 2001;8(3):204-8.
16. Xue Y, Thakuria M. Merkel cell
carcinoma review. Hematology/Oncology Clinics. 2019;33(1):39-52.
17. Becker JC, Stang A, DeCaprio JA,
Cerroni L, Lebbé C, Veness M, et al. Merkel cell carcinoma. Nature
reviews Disease primers. 2017;3(1):1-17.
18. Tello TL, Coggshall K, Yom SS, Yu
SS. Merkel cell carcinoma: An update and review: Current and future
therapy. J Am Acad Dermatol. 2018;78(3):445-54.
19. Barreira JV, Valejo Coelho MM.
Unknown primary Merkel cell carcinoma with cutaneous spread. 2019;12(2).
20. Agut-Busquet E, Yebenes M, Luelmo
J. Stony-Hard Subcutaneous Mass on the Arm of a Young Woman. Actas
dermo-sifiliograficas. 2016;107(2):149-50.
21. Leroux-Kozal V, Lévêque N,
Brodard V, Lesage C, Dudez O, Makeieff M, et al. Merkel cell carcinoma:
histopathologic and prognostic features according to the
immunohistochemical expression of Merkel cell polyomavirus large T
antigen correlated with viral load. Human pathology. 2015;46(3):443-53.
22. Panse G, McNiff JM, Ko CJ. Basal
cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the
differential diagnosis with Merkel cell carcinoma. Journal of cutaneous
pathology. 2017;44(6):553-6.
23. Kontochristopoulos GJ,
Stavropoulos PG, Krasagakis K, Goerdt S, Zouboulis CC. Differentiation
between merkel cell carcinoma and malignant melanoma: An
immunohistochemical study. Dermatology (Basel, Switzerland).
2000;201(2):123-6.
24. Battifora H, Silva EG. The use of
antikeratin antibodies in the immunohistochemical distinction between
neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat
cell carcinoma. Cancer. 1986;58(5):1040-6.
25. Sur M, AlArdati H, Ross C,
Alowami S. TdT expression in Merkel cell carcinoma: potential diagnostic
pitfall with blastic hematological malignancies and expanded
immunohistochemical analysis. Modern pathology : an official journal of
the United States and Canadian Academy of Pathology, Inc.
2007;20(11):1113-20.
26. Fernandez-Flores A,
Suarez-Penaranda JM, Alonso S. Study of EWS/FLI-1 rearrangement in 18
cases of CK20+/CM2B4+ Merkel cell carcinoma using FISH and correlation
to the differential diagnosis of Ewing sarcoma/peripheral
neuroectodermal tumor. Applied immunohistochemistry & molecular
morphology : AIMM. 2013;21(5):379-85.
27. Becker JC, Lorenz E, Ugurel S,
Eigentler TK, Kiecker F, Pföhler C, et al. Evaluation of real-world
treatment outcomes in patients with distant metastatic Merkel cell
carcinoma following second-line chemotherapy in Europe. Oncotarget.
2017;8(45):79731.
28. Nghiem P, Bhatia S, Lipson EJ,
Sharfman WH, Kudchadkar RR, Brohl AS, et al. Durable tumor regression
and overall survival in patients with advanced Merkel cell carcinoma
receiving pembrolizumab as first-line therapy. Journal of Clinical
Oncology. 2019;37(9):693.